Aortic Stents Grafts Market: Abdominal Aortic Stent Graft to Remain Dominant Product Type Through 2027
Click here For Free Sample Report @ https://www.mrrse.com/sample/3997
Growing prevalence of obesity continues to impact health of the patients adversely. Prevalence of obesity is bound to various factors such as improper diet, chronic stress and intake of medications for diabetes and depression. Untreated obesity has led to health issues such as diabetes, sleep apnea, high blood pressure, heart disease, cancer, osteoarthritis and psychosocial effects.
According to Market Research Reports Search Engine (MRRSE), the global anti-obesity prescription drugs market is expected to represent a value of over US$ 1,000 Mn by the end of 2026.
Cholesterol-Rich Food Products to Boost Sales
According to a recent report by CDC, over one-third of the adults in the U.S. have obesity. Consumption of the food products that are high in cholesterol has been a major contributor to the obese population. Increasing consumption of the unhealthy food products such as potato chips, meat, bacon, chocolates and other sugary treats has led to growing prevalence of obesity globally. Moreover, surge in consumption of alcoholic beverages is further expected to contribute towards obesity. Growing prevalence of obesity due to increasing consumption of cholesterol-rich and unhealthy food products and beverages is likely to impact growth of the global obesity prescription drugs market positively.
Chronic Stress to Contribute towards Obesity
Increasing level of stress can lead people to consume unhealthy food products that hinder the brain activity and have a counteracting effect on the emotional and physical stress. In addition, surge in the stress level leads to “comfort eating”, due to which the end users are more prone to obesity. Moreover, prolonged stress due to emotional pressure leads the brain to release cortisol hormones, which increases the appetite levels in the person. Eating disorders and consumption of unhealthy food products lead to long-term problems for the blood vessels and heart. Consumption of unhealthy food products and beverages in order to counter stress-related problems further contributes towards obesity. Bound to these factors, the global anti-obesity prescription drugs market is expected to witness positive growth during the forecast period.
To know the latest trends and insights click the link below: https://www.mrrse.com/antiobesity-prescription-drugs-market
Appetite Stimulating Side-Effects of Psychotropic Drugs to Fuel Demand for Obesity Management
Obesity has also been a result of consuming drugs for diabetes such as sulfonylureas, insulin and thiazolidinediones. A recent report by CDC states that 9.4% of the population in the U.S. have diabetes. Consumption of drugs for diabetes stimulate appetite, due to which the patients eat more and gain weight. Moreover, obesity is also a common side-effect of consuming antidepressants drugs. As consumption of anti-depressant drugs stimulate hunger, consumers tend to eat more. These factors further contribute towards prevalence of obesity globally. Surge in the obese population is attributed to increasing consumption of the antidepressant and diabetes drugs, which is expected to impact growth of the global anti-obesity prescription drugs market.
Practicing Yoga Exercises to Inhibit Market Growth
On the other hand, various factors are expected to inhibit growth of the global anti-obesity prescription drugs market. Obese people are increasingly opting for various exercises that enable them to lose weight. As yoga practices are becoming popular, obese patients are increasingly practicing yoga exercises in order to reduce the weight and treat hypertension. In order to shed body fats, the obese people are increasingly opting for sugar free food products and planning diets that help in reducing weight of the end users. These factors are expected to impact growth of the global anti-obesity prescription drugs market negatively.
Liraglutide Drug Class to Represent a Leading Segment
With the increasing blood sugar levels, doctors are prescribing the liraglutide medicines to the patients in order to reduce the risk of obesity. On the basis of drug class, the liraglutide segment is expected to represent the highest revenue growth, accounting for a value of over US$ 100 Mn by the end of 2026. On the other hand, the bupropion and naltrexone drug class segment is expected to register a robust CAGR during the forecast period.
Based on age group, the adult segment is expected to witness the highest growth in terms of revenue, recording a value of over US$ 100 Mn by the end of 2017. Along with the pediatric age group segment, the adult age group segment is expected to register a healthy CAGR through 2026.
By distribution channel, the hospital pharmacies segment is expected to represent significant revenue growth, representing a value of over US$ 100 Mn by the end of 2026. Moreover, the hospital pharmacies distribution channel segment is expected to register the highest CAGR during the forecast period.
Leading market players operating in the global anti-obesity prescription drugs market include F Hoffmann La Roche Ltd, Orexigen Therapeutics, Inc, Arena Pharmaceuticals, Inc, VIVUS, Inc and Novo Nordisk A/S.
Enquire about this Report @ https://www.mrrse.com/enquiry/3997
Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.
MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.
90, State Street
Albany, NY - 12207
Website : https://www.mrrse.com/
Read More Industry News At: https://www.industrynewsanalysis.com/
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Aortic Stents Grafts Market: Abdominal Aortic Stent Graft to Remain Dominant Product Type Through 2027 here
News-ID: 952053 • Views: 142
More Releases from Market Research Reports Search Engine - MRRSE
Global Video Event Data Recorder Market: Industry Analysis and Opportunity Asses …
In order to study the various trends and patterns prevailing in the concerned market, Market Research Reports Search Engine (MRRSE) has included a new report titled “Video Event Data Recorder Market” to its wide online database. This research assessment offers a clear insight about the influential factors that are expected to transform the global market in the near future. To Get Sample Report @ https://www.mrrse.com/sample/2941 The global video event data recorder (VEDR)
Global Octabin Market key Insights Based On Product Type, End-use and Regional D …
In order to study the various trends and patterns prevailing in the concerned market, Market Research Reports Search Engine (MRRSE) has included a new report titled “Octabin Market” to its wide online database. This research assessment offers a clear insight about the influential factors that are expected to transform the global market in the near future. Get Sample Report with More Info @ https://www.mrrse.com/sample/16143 Packaging solutions for bulk cargo are gaining fast
Global Ion Beam Technology Market Examines Latest Trends and Key Drivers Support …
In order to study the various trends and patterns prevailing in the concerned market, Market Research Reports Search Engine (MRRSE) has included a new report titled“Global Ion Beam Technology Market”to its wide online database. This research assessment offers a clear insight about the influential factors that are expected to transform the global market in the near future. Click here – Request Sample Report @ https://www.mrrse.com/sample/3126 Application of ion beam was rarely found
Cash- in Transit Bags Market 2025 | Global Key Players: TruSeal (Pty) Ltd, Harco …
This report on the Global Cash-in Transit Bags Market provides analysis for the period 2015–2025, wherein 2016 is the base year and the period from 2017 to 2025 is the forecast period. Data for 2015 has been included as historical information. The report covers market dynamics including drivers, restraints, opportunities, trends, and policies and regulations which are expected to influence the cash-in transit bags market growth during the said period.
More Releases for Obesity
Sternal Closure System Market Demand Obesity 2025
Global Sternal Closure System Market: Overview Sternal closure is necessitated by a heart surgery or surgeries of the thoracic cavities. It is used to close the sternum. A perfect sternal closure is predicted to bring about stability, lessen post-operative complications, and also reduce hospitalization stay. Overall, it is meant to be cost-effective. The market for sternal closure systems has been rising steadily because of the surging patient population, alongside the increasing
Obesity Management Congress 2018
Obesity can be managed by combination of lifestyle change, exercise and healthy diet plans. In case of severe Obesity bariatric surgery and medications will be employed. People who have gone through bariatric surgery which have suppressed hunger and the mechanism for which causes obesity based type 2 diabetes is reversed and it also causes sixty to eighty percent weight loss for a long term. But it has it cons
Obesity Therapeutic and Disease Pipeline Review H2
Summary Obesity is defined as having an excessive amount of body fat. Obesity increases risk of diseases and health problems such as heart disease, diabetes and high blood pressure. The predisposing factors include age, family history, quitting smoking, lack of sleep and certain medications. Treatment includes healthy lifestyle, medications and surgery. Report Highlights Pharmaceutical and Healthcare latest pipeline guide Obesity - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development
Obesity Management Market | Global Industry Analysis 2027
High costs involved in the research & development (R&D) of obesity drugs, coupled with limited financial support, are collectively a great challenge for adoption of obesity management solutions. Additionally, long gestation time needed for R&D activities, and the inclusion of clinical trials required to test these drugs hikes the expenditure significantly. Considering this scenario, manufacturers are being cautious while seeking better return on investments. In the long run, risks and
Obesity Treatment Market driven by rise in childhood obesity rates
Obesity is a disorder in which excess body fat gets accumulated to such extent that it may have negative effects on health. It occurs over time when people eat more calories than they utilize. The reasons for obesity can be medical problems, inactivity, genetics, family lifestyle, unhealthy diet, medications, age, and pregnancy. Being obese increases the risk of diabetes, heart disease, stroke, arthritis, and some type of cancers. Obesity treatment
Obesity - Pipeline Review, H2 2016: Ken Research
Global Markets Direct’s, ‘Obesity - Pipeline Review, H2 2016’, provides an overview of the Obesity pipeline landscape. The report provides comprehensive information on the therapeutics under development for Obesity, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press